##plugins.themes.academic_pro.article.main##

Abstract

Endocrine disorders are of primary importance in the occurrence and progression of rheumatic diseases. Often, endocrine restructuring that occurs during puberty, menopause, pregnancy, childbirth, and abortion serves as a background for the development of connective tissue diseases. At the same time, the change in neuroendocrine status is an integral component of the progression of rheumatic diseases. Especially distinct hormonal shifts were found on the part of the thyroid gland in rheumatoid arthritis (RA). The prevalence of thyroid pathology in general among patients with rheumatoid arthritis, according to literature data, reaches 34%, and Hashimoto's thyroiditis, according to various authors, from 4 to 13.5%. In addition, the greatest susceptibility to RA in women of reproductive age indicates a certain role of sex hormones in the pathogenesis of the disease. Metabolic and degenerative changes in connective tissue largely determine the pathogenesis and clinical picture of various diseases. Rheumatic diseases, the most common of which is rheumatoid arthritis (RA), make up a significant proportion of the pathology of the joints, musculoskeletal system, and connective tissue. It affects 0.5—1% of the world's population, which is about 63 million patients.

Keywords

rheumatoid arthritis autoimmune thyroiditis hypothyroidism

##plugins.themes.academic_pro.article.details##

How to Cite
Shodikulova Gulandom Zikiryayevna, Shonazarova Nodira Xudoyberdiyevna, & Sheranov Atxam Mamadiyarovich. (2022). Pathology of the Thyroid Gland in Women Rheumatoid Arthritis. Texas Journal of Medical Science, 15, 73–77. https://doi.org/10.62480/tjms.2022.vol15.pp73-77

References

  1. Zikiryayevna, S. G., Xudoyberdiyevna, S. N., & Jamshedovich, V. J. (2022). FEATURES OF PATHOLOGY THYROID GLAND IN A WOMAN WITH RHEUMATOID ARTHRITIS. Spectrum Journal of Innovation, Reforms and Development, 4, 49-54.
  2. Насирова, А., Курбанова, З., & Шоназарова, Н. (2020). КЛИНИКО-ИММУНОЛОГИЧЕСКИЕ ОСОБЕННОСТИ СОЧЕТАНИЯ БРОНХИАЛЬНОЙ АСТМЫ И ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ. Журнал кардиореспираторных исследований, 1(1), 81-84.
  3. Шодикулова, Г. З., Шоназарова, Н. Х., & Шеранов, А. М. (2022). ХАРАКТЕРИСТИКА КОМОРБИДНОГО РЕВМАТОИДНОГО АРТРИТА И ГИПОТИРЕОЗА. Достижения науки и образования, (3 (83)), 88-91.
  4. Шодикулова, Г. З., & Шоназарова, Н. Х. (2022). REVMATOID ARTRIT VA GIPOTIREOZ KASALLIKLARI KOMORBID KECHISHINING O ‘ZIGA XOS XUSUSIYATLARI. Журнал кардиореспираторных исследований, (SI-2).
  5. Шодикулова, Г. З., & Шоназарова, Н. Х. (2022). REVMATOID ARTRIT BILAN KASALLANGAN KARDIOMETABOLIK SINDROMI BOR BEMORLARDA QALQONSIMON BEZ KASALLIKLARNING O ‘ZIGA XOS XUSUSIYATLARI. Журнал кардиореспираторных исследований, 3(2).
  6. Alisherovna, K. M., Rustamovich, T. D., Baxtiyorovich, U. J., & Sherzodovna, M. D. (2022). KIDNEY DAMAGE IN CHRONIC HEART FAILURE. Web of Scientist: International Scientific Research Journal, 3(10), 744-752.
  7. Alisherovna, K. M., Rustamovich, T. D., Baxtiyorovich, U. J., & Sobirovna, S. M. (2022). Diabetes Mellitus and Hyperglycemia in Patients with Rheumatoid Arthritis. Texas Journal of Medical Science, 13, 99-103.
  8. Alisherovna, K. M., Rustamovich, T. D., & Baxtiyorovich, U. J. (2022). The Use of Trimetazidine in Patients with Type 2 Diabetes Mellitus Who Have Suffered a Myocardial Infarction. Czech Journal of Multidisciplinary Innovations, 10, 35-41.
  9. Zikiryayevna, S. G., Muxtorovna, E. M., Mamadiyarovich, S. A., & To’raqulovna, Q. S. (2022). KIDNEY DAMAGE IN RHEUMATOID ARTHRITIS: RELATIONSHIP WITH CARDIOVASCULAR RISK FACTORS. Galaxy International Interdisciplinary Research Journal, 10(5), 857-862.
  10. Zikiryayevna, S. G., Zohirovna, M. G., Muxtorovna, E. M., & Bahromovich, S. S. (2022). Kidney Damage in Patients with Chronic Cardiac Insufficiency and Obesity. Texas Journal of Medical Science, 13, 72-78.
  11. Zikiryayevna, S. G., Muxtorovna, E. M., Mamadiyarovich, S. A., & Jurayevich, M. E. (2022). EVALUATION OF 12-WEEK URATE-REDUCING THERAPY WITH ALLOPURINOL IN COMBINATION WITH THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG MELOXICAM IN PATIENTS WITH GOUT. Galaxy International Interdisciplinary Research Journal, 10(6), 140-148.
  12. Ярмухаммедова, С. (2020). ОЦЕНКА ПРИЗНАКОВ ДИАСТОЛИЧЕСКОЙ ДИСФУНКЦИИ ПРАВОГО ЖЕЛУДОЧКА У БОЛЬНЫХ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ. Журнал кардиореспираторных исследований, 1(2), 88-92.
  13. Ярмухамедова, С. Х., & Афмирова, Ш. А. (2022). Изменения диастолической функции правого желудочка при гипертонической болезни. Science and Education, 3(11), 270-280.
  14. Yarmukhamedova, S. (2020). SURUNKALI GLOMERULONEFRIT BILAN OG ‘RIGAN BEMORLARDA ARTERIAL QON BOSIMINING SUTKALIK MONITORING KO ‘RSATKICHLARINI BAXOLASH. Журнал кардиореспираторных исследований, 1(1), 103-108.
  15. Nizamitdinovich, K. S., Alisherovna, K. M., Erkinovna, K. Z., & Davranovna, M. K. (2022). Heart Lesions in Rheumatological Diseases. Texas Journal of Medical Science, 13, 91-94.
  16. Davranovna, M. K., Alisherovna, K. M., Erkinovna, K. Z., & Nizamitdinovich, K. S. (2022). Assessment of the Quality of Life of Patients with Coronary Heart Disease. The Peerian Journal, 11, 44-50.
  17. Erkinovna, K. Z., Alisherovna, K. M., Davranovna, M. K., & Nizamitdinovich, K. S. (2022). Correction of Cytokine Imbalance in the Treatment of Stable Angina Pectoris. The Peerian Journal, 11, 64-70.
  18. Alisherovna, K. M., Nizamitdinovich, K. S., Davranovna, M. K., & Erkinovna, K. Z. (2022). Kidney Condition in Patients with Myocardial Infarction. Texas Journal of Medical Science, 13, 85-90.
  19. Эргашева, М. Т. (2022). АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ У ЖЕНЩИН В ПОСТМЕНОПАУЗЕ. Журнал кардиореспираторных исследований, (SI-2).
  20. Alisherovna, K. M., Toshtemirovna, E. M. M., Duskobilovich, B. S., & Umirxanovna, K. G. (2022). DYSFUNCTION LEFT VENTRICULAR IN BRONCHIAL ASTHMA. Spectrum Journal of Innovation, Reforms and Development, 4, 216-221.
  21. Totlibayevich, Y. S., Alisherovna, K. M., Xudoyberdiyevich, G. X., & Toshtemirovna, E. M. M. (2022). Risk Factors for Kidney Damage in Rheumatoid Arthritis. Texas Journal of Medical Science, 13, 79-84.
  22. Xudoyberdiyevich, G. X., Alisherovna, K. M., Toshtemirovna, E. M. M., & Totlibayevich, Y. S. (2022). Characteristics Of Neuropeptides-Cytokines in Patients with Cardiovascular Pathology Occurring Against the Background of Anxiety and Depressive Disorders. The Peerian Journal, 11, 51-57.
  23. Nazarov, F. Y. (2021). CHANGES IN CYTOKINE SPECTRA AND THEIR SIGNIFICANCE IN COVID-19 VIRAL INFECTION COMPLICATED WITH PNEUMONIA. Web of Scientist: International Scientific Research Journal, 2(06), 62-69.
  24. Nazarov, F. Y., & Makhmudova, K. D. (2022). THE USE OF STATINS AND DRUGS THAT INHIBIT THE ABSORPTION OF CHOLESTEROL IN PATIENTS WITH CORONARY HEART DISEASE. Galaxy International Interdisciplinary Research Journal, 10(1), 306-309.
  25. Khusainova, M., & Nazarov, F. (2021). Features of the circadian rhythm blood pressure in patients heart failure and impaired renal function. InterConf.
  26. Nazarov, F. Y. (2021). CORRECTION OF HEMODYNAMIC DISORDERS IN PATIENTS WITH OUTSIDE BILATERAL TOTAL PNEUMONIA. Web of Scientist: International Scientific Research Journal, 2(11), 151-155.

Most read articles by the same author(s)